Abstract
Context: Conflict of interest has always been one of the challenges facing healthcare systems. The pharmaceutical sector is one of the main components of healthcare systems affected by conflicts of interest. Objectives: This systematic review investigated strategies to manage conflicts of interest in the pharmaceutical sector. Methods: In this systematic review, EMBASE, PubMed, Scopus, Web of Science, and Google Scholar were searched using the keywords "conflict of interest" and "pharmaceutical sector" without a time limitation until 2024. The quality of studies was assessed using JBI checklists. Results: A total of 6,217 records were retrieved from the databases, out of which 46 were included in the review. The main strategies for managing conflicts of interest include industry relationship management, empowerment, and transparency and disclosure. These strategies are carried out and supported by two mechanisms: Legislation and self-regulation. Conclusions: Conflicts of interest in the pharmaceutical sector can be addressed through the management of communications, empowerment, education, and, most importantly, transparency in financial and non-financial relationships. These efforts can be supported by government regulations or industry-based self-regulation. Such actions must be implemented and coordinated within the health system.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
